I watch the FDA closely, but have a vested interest in drugs approved for the treatment of Multiple Sclerosis. Apparently, Michelle Obama and I have something in common – a parent with MS. So I was interested in today’s Wall Street Journal which reports Biogen will be working with the FDA to change labeling for a new MS drug, called Tysabri.

According to the manufacturer’s website on Tysabri, the rare brain disorder may cause death or disability. The drug may also cause liver damage, urinary tract infections, lung disease etc.

Bottom line – there are always side effects to every drug…. And in my personal experience, no MS drug is a clear solution… so please, when recommended by a doctor, investigate before you sign up for a new drug!

Lauren Ellerman
Lauren Ellerman

In 2011, Lauren Ellerman was named "Young Lawyer of the Year" by the Roanoke Bar Association for her work in the community. To speak with Lauren about your personal injury case, contact her at